MedPath

Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT

Completed
Conditions
Re-entrant Atrioventricular Tachycardia
Tachycardia, Atrioventricular Nodal Reentry
Interventions
Procedure: RFA
Registration Number
NCT01594814
Lead Sponsor
National Institute of Cardiology, Warsaw, Poland
Brief Summary

Atrioventricular nodal reciprocating tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT) are two similar supraventricular re-entry tachycardias (SVT) emerging in relatively young age in patients without apparent structural heart disease or significant comorbidities. The treatment of choice in those patients is radiofrequency ablation (RFA).

The PPRA study is a prospective observational study developed to thoroughly analyze quality of life, utility and willingness-to-pay of Polish patients undergoing RF ablation of AVNRT or AVRT.

Based on collected data the investigators will prepare a profile of patient who will benefit most from radiofrequency ablation and who should be scheduled in first place for the ablation in case of problems with accessibility to this service.

What is more an analysis of medical and indirect costs of care will be performed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  1. Written informed consent
  2. Age above 18
  3. Scheduled RFA due to AVNRT or AVRT
  4. Sufficient knowledge of the Polish language to independently complete the questionnaires
Exclusion Criteria
  1. No written informed consent
  2. Health states significantly impairing QoL (eg. stroke, advanced heart failure)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
RFA of AVNRT of AVRTRFA-
Primary Outcome Measures
NameTimeMethod
Health-related quality of life (HRQOL)two months

Mean score of Patient Perception of Arrhythmia Questionnaire (PPAQ) - a disease-specific QoL questionnaire for patients suffering from supraventricular tachycardia translated and validated according to ISPOR (International Society For Pharmacoeconomics and Outcomes Research) guidelines

Secondary Outcome Measures
NameTimeMethod
Effectivenesstwo days

Data on medical history, final diagnosis, outcome of treatment, safety and future recommendations

Utility of health statetwo months

Mean score of EQ-5D - a generic questionnaire measuring a health state utility (official Polish translation)

Medical and indirect costone year

Cross-sectional data gathered using original questionnaire designed to measure medical and indiresct costs related to arrhythmia incurred during a year preceding RFA

Willingness-to-payone day

a cross-sectional willingness-to-pay questionnaire studying hypothetical situation where RFA was not financed by Polish Health Fund

Trial Locations

Locations (1)

Institute of Cardiology, II Dept. of Coronary Heart Disease

🇵🇱

Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath